Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  11.00 4.42% 260.00 206,050 16:29:57
Bid Price Offer Price High Price Low Price Open Price
260.00 263.00 267.00 242.00 249.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 12.84 -53.67 -12.55 735
Last Trade Time Trade Type Trade Size Trade Price Currency
17:20:35 O 234 260.00 GBX

Puretech Health (PRTC) Latest News (3)

More Puretech Health News
Puretech Health Takeover Rumours

Puretech Health (PRTC) Discussions and Chat

Puretech Health Forums and Chat

Date Time Title Posts
12/12/201914:19PureTech Health - innovative healthcare466
22/7/201820:35PureTech Health (PRTC) One to Watch Monday -

Add a New Thread

Puretech Health (PRTC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
18:29:49260.00234608.40O
17:16:22260.01108280.81O
17:07:23260.001,9004,940.00O
16:37:39260.001,1272,930.20AT
16:37:39260.0066171.60AT
View all Puretech Health trades in real-time

Puretech Health (PRTC) Top Chat Posts

DateSubject
12/12/2019
08:20
Puretech Health Daily Update: Puretech Health Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 249p.
Puretech Health Plc has a 4 week average price of 196p and a 12 week average price of 196p.
The 1 year high share price is 307p while the 1 year low share price is currently 155.50p.
There are currently 282,679,696 shares in issue and the average daily traded volume is 123,036 shares. The market capitalisation of Puretech Health Plc is £734,967,209.60.
10/12/2019
19:19
lendmeafiver: Further good news flow here today and KRTX looking solid, whilst the PRTC share price seems to be all over the place on minimal volume.
09/12/2019
19:52
rambutan2: Gelesis Secures Over $84 Million in New Capital to Support Commercialisation of PLENITY(TM) Vitruvian Partners leads a $63.4 million equity round, complemented by $21.2 million in new, non-dilutive grant funding and loans to further support commercialisation efforts... https://uk.advfn.com/stock-market/london/puretech-health-PRTC/share-news/PureTech-Health-PLC-Gelesis-Attracts-84M-in-New-C/81305273
20/11/2019
23:58
lendmeafiver: PureTech saw its 31.6% stake in the US company rise to US$580mln from US$130mln at the end of last week, although its share price went up only 13%, compared to the 70% expected by broker Peel Hunt. “This valuation dislocation is unsustainable in our view,” analysts said in a note. www.proactiveinvestors.co.uk/companies/news/907353/puretech-health-surges-as-karuna-investment-rockets-442-907353.html
01/10/2019
18:29
rambutan2: Some heavyweight appointments at Vor 1 October 2019 PureTech Health plc PureTech Affiliate Vor Biopharma Appoints Senior Cell and Gene Therapy Leaders PureTech Health plc (LSE: PRTC) ("PureTech"), a clinical stage biotechnology company dedicated to discovering, developing and commercialising highly differentiated medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, is pleased to note that its affiliate Vor Biopharma has appointed Sadik Kassim, PhD, previously of Kite Pharma and Novartis, as chief technology officer, and Tirtha Chakraborty, PhD, previously of Sana Biotechnology and CRISPR Therapeutics, as vice president of research. The full text of the announcement from Vor Biopharma is as follows: https://uk.advfn.com/stock-market/london/puretech-health-PRTC/share-news/PureTech-Health-PLC-Vor-Appoints-Senior-Cell-Gen/80836761
30/9/2019
11:29
lendmeafiver: Well this takeover rumour hasn’t exactly ignited the share price yet!
23/9/2019
11:35
lendmeafiver: Not sure why the share price has reacted so negatively today but I’ve bought a few more for a price that I didn’t think we would see again.
10/6/2019
18:41
lendmeafiver: I agree, always been very impressed by Daphne Zohar. Share price seems to be going vertical.
04/6/2019
16:38
lendmeafiver: Yes I had noticed Woodford wasn’t in here, share price flying again.
02/5/2019
17:08
lendmeafiver: Agree. Surely given recent progress an ipo or other transaction at Gelesis has to be on the cards, will have a huge impact on the Prtc share price I expect.
16/4/2019
19:31
lendmeafiver: Been looking forward to the approval of Gelesis100 and pleased to see it has created a bit of interest here. When I first invested here I took the view that Gelesis very much covered the downside with all the other puretech pipelines being almost for free in the share price, I very much believe that to be the case now in my opinion. Like the name Plenity also.
Puretech Health share price data is direct from the London Stock Exchange
Your Recent History
LSE
PRTC
Puretech H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 20:10:12